Ineos boss ‘doesn’t mind being unpopular’, but would draw the line if it reached extent of vitriol heaped on club’s majority owners ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other most profitable biotech stocks to buy right now. With improved market ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Great Place to Work® and Fortune magazine recognized the company as one of the Fortune 100 Best ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Apr 2, 2025-- ...

Biotech investors are grappling with fresh uncertainty following the abrupt resignation of Dr. Peter Marks, a key figure in the US Food and Drug Administration. Marks, who was instrumental in ...

All three companies are early-stage biotechnology companies working on next-generation therapeutics with advanced ... Over the weekend, Dr. Peter Marks, who headed the FDA's Center for Biologics ...

Morning. Today, we process the shockwaves in biotech following the ouster of CBER chief Peter Marks, see a radiopharmaceutical expand its reach, and more. Robert F. Kennedy Jr.’s abrupt ousting ...

Peter Marks resigns from FDA ... Moderna tumbled 13%, Beam Therapeutics—known for its gene-editing technology—fell over 15%, and gene therapy developer Sarepta Therapeutics lost 9%.

We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands ...

3 Reasons Investors Watch United Therapeutics (UTHR) Over the last six months, United Therapeutics shares have sunk to $308.27, producing a disappointing 14% loss - worse than the S&P 500’s 1.4% ...

Former England and Lancashire fast bowler Peter Lever has died at the age of 84 after a short illness. Lever, who played 17 Tests for his country, was part of the 1970/71 away Ashes triumph and ...